• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

管理他莫昔芬使用者的更年期症状和抑郁:药物和药物相互作用的影响。

Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions.

机构信息

Allan Memorial Institute, McGill University Health Centre, Montreal, Quebec, Canada.

出版信息

Maturitas. 2010 Dec;67(4):296-308. doi: 10.1016/j.maturitas.2010.08.005. Epub 2010 Sep 28.

DOI:10.1016/j.maturitas.2010.08.005
PMID:20880642
Abstract

OBJECTIVE

Tamoxifen, a medication used in the treatment of breast cancer, often induces menopausal symptoms. Certain medications and natural supplements taken or prescribed to alleviate tamoxifen-induced hot flashes and depressive states in women with breast cancer interact with tamoxifen. This paper reviews potentially problematic interactions and offers treatment recommendations.

METHODS

Medline (1950-June 1, 2010), Embase Classic+Embase (1947-June 1, 2010) and PsycINFO (1967-June 1, 2010) were searched through Ovid. The word "tamoxifen" was searched with "depression" and then with "menopaus*" and "symptoms", with "treatment" as a limit. "Tamoxifen" was later searched with the MeSH terms "drug interaction" or "drug incompatibility".

RESULTS

Venlafaxine is efficacious for the treatment of hot flashes and depression and safe to use in combination with tamoxifen. Gabapentin is also efficacious in treating tamoxifen-induced hot flashes and, since it does not interact with cytochrome P450 system, is likely safe to use in patients using tamoxifen. Desvenlafaxine and pregabalin may be alternatives to venlafaxine and gabapentin, respectively, although desvenlafaxine has not yet been studied in this population. Paroxetine, fluoxetine and bupropion are strong CYP2D6 inhibitors which should be avoided in tamoxifen users. Fluvoxamine and nefazodone both inhibit CYP3A, which could potentially affect the metabolism of tamoxifen. Clonidine can be an alternative agent but may carry significant side effects. Evidence of medicinal products for the treatment of tamoxifen-induced hot flashes is equivocal at best.

CONCLUSIONS

Clinicians should remain cautious about using strong inhibitors and/or inducers of cytochrome 2D6 and 3A4 concomitantly with tamoxifen. Use of natural menopausal supplements and diets rich in isoflavones should not be encouraged in tamoxifen users until more data is available. There are however safe treatments for hot flashes and depression in tamoxifen users.

摘要

目的

他莫昔芬是一种用于治疗乳腺癌的药物,常引起绝经症状。某些药物和天然补充剂用于缓解乳腺癌女性因他莫昔芬引起的热潮红和抑郁状态,与他莫昔芬相互作用。本文综述了潜在的问题相互作用,并提出了治疗建议。

方法

通过 Ovid 检索 Medline(1950 年-2010 年 6 月 1 日)、Embase Classic+Embase(1947 年-2010 年 6 月 1 日)和 PsycINFO(1967 年-2010 年 6 月 1 日)。用“他莫昔芬”搜索“抑郁”,然后用“绝经”和“症状”,以“治疗”为限制。随后,用 MeSH 术语“药物相互作用”或“药物不相容性”搜索“他莫昔芬”。

结果

文拉法辛治疗热潮红和抑郁有效,与他莫昔芬联合使用安全。加巴喷丁也能有效治疗他莫昔芬引起的热潮红,由于它不与细胞色素 P450 系统相互作用,因此在使用他莫昔芬的患者中使用可能是安全的。去甲文拉法辛和普瑞巴林可能分别是文拉法辛和加巴喷丁的替代品,尽管去甲文拉法辛尚未在该人群中进行研究。帕罗西汀、氟西汀和安非他酮是强 CYP2D6 抑制剂,应避免在他莫昔芬使用者中使用。氟伏沙明和奈法唑酮均可抑制 CYP3A,这可能会影响他莫昔芬的代谢。可乐定可以作为替代药物,但可能会产生严重的副作用。治疗他莫昔芬引起的热潮红的药物证据充其量也只是模棱两可的。

结论

临床医生应谨慎使用与他莫昔芬同时使用的强细胞色素 2D6 和 3A4 抑制剂和/或诱导剂。在有更多数据之前,不应鼓励他莫昔芬使用者使用天然绝经补充剂和富含异黄酮的饮食。然而,他莫昔芬使用者有安全的热潮红和抑郁治疗方法。

相似文献

1
Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions.管理他莫昔芬使用者的更年期症状和抑郁:药物和药物相互作用的影响。
Maturitas. 2010 Dec;67(4):296-308. doi: 10.1016/j.maturitas.2010.08.005. Epub 2010 Sep 28.
2
Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.舍曲林(左洛复)治疗早期乳腺癌服用他莫昔芬女性潮热的随机、双盲、安慰剂对照、交叉研究。
Breast J. 2006 Mar-Apr;12(2):114-22. doi: 10.1111/j.1075-122X.2006.00218.x.
3
Menopausal symptoms following tamoxifen treatment for breast cancer.乳腺癌患者接受他莫昔芬治疗后的更年期症状。
Oncology (Williston Park). 2008 Apr;22(4 Suppl Nurse Ed):46-8.
4
Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.芳香化酶抑制剂与他莫昔芬的副作用:患者视角
Am J Surg. 2006 Oct;192(4):496-8. doi: 10.1016/j.amjsurg.2006.06.018.
5
Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.激素替代疗法对他莫昔芬所致血管舒缩症状的影响。
J Clin Oncol. 2006 Aug 20;24(24):3991-6. doi: 10.1200/JCO.2005.04.3745.
6
Tamoxifen and depression: drug interactions in breast cancer.他莫昔芬与抑郁症:乳腺癌中的药物相互作用
Consult Pharm. 2013 Sep;28(9):584-91. doi: 10.4140/TCP.n.2013.584.
7
Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.两剂醋酸甲地孕酮治疗乳腺癌女性更年期症状的III期随机安慰剂对照试验:西南肿瘤学组研究9626
J Clin Oncol. 2008 Apr 1;26(10):1650-6. doi: 10.1200/JCO.2006.10.6179.
8
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.乳腺癌与抑郁症治疗中的药物相互作用及药物基因组学
Am J Psychiatry. 2008 Oct;165(10):1251-5. doi: 10.1176/appi.ajp.2008.08040482.
9
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.对于有患乳腺癌高风险的女性,在他莫昔芬治疗基础上加用激素疗法并不能预防潮热。
Breast Cancer Res Treat. 2009 Aug;116(3):521-7. doi: 10.1007/s10549-008-0284-y. Epub 2009 Jan 13.
10
Ask the doctor. I've been taking tamoxifen for several months after completing treatment for breast cancer. My doctor prescribed it primarily to lower my risk of developing cancer in my unaffected breast. As a result of chemotherapy, I underwent menopause abruptly. Tamoxifen has worsened my symptoms, especially hot flashes and vaginal dryness. Other than stopping the tamoxifen, are there ways to deal with the side effects?
Harv Womens Health Watch. 1999 May;6(9):8.

引用本文的文献

1
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data.基于整合的临床I期和II期数据的elinzanetant群体药代动力学-药效学模型。
CPT Pharmacometrics Syst Pharmacol. 2024 Dec;13(12):2137-2149. doi: 10.1002/psp4.13226. Epub 2024 Sep 18.
2
Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trial.去甲文拉法辛对服用他莫昔芬的乳腺癌女性潮热的不同影响:一项随机对照试验。
NPJ Breast Cancer. 2024 Jul 17;10(1):59. doi: 10.1038/s41523-024-00668-w.
3
Vasomotor Symptoms During Menopause: A Practical Guide on Current Treatments and Future Perspectives.
更年期血管舒缩症状:当前治疗方法及未来展望实用指南
Int J Womens Health. 2023 Feb 14;15:273-287. doi: 10.2147/IJWH.S365808. eCollection 2023.
4
Prevalence of the co-prescription of tamoxifen and CYP2D6 inhibitors in Saudi population: A cross sectional study.沙特人群中他莫昔芬与CYP2D6抑制剂联合处方的患病率:一项横断面研究。
Saudi Pharm J. 2020 Apr;28(4):440-444. doi: 10.1016/j.jsps.2020.02.004. Epub 2020 Feb 17.
5
The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview.乳腺癌女性绝经症状的管理:概述
Drugs Aging. 2018 Aug;35(8):699-705. doi: 10.1007/s40266-018-0574-y.
6
A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients.对更年期和癌症患者血管舒缩症状非激素治疗的系统评价。
Springerplus. 2015 Feb 10;4:65. doi: 10.1186/s40064-015-0808-y. eCollection 2015.
7
Pharmacological management of depression in patients with cancer: practical considerations.癌症患者抑郁的药物治疗管理:实用考虑。
Drugs. 2013 Jul;73(11):1131-45. doi: 10.1007/s40265-013-0090-7.
8
Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.2004-2010 年乳腺癌女性中抗抑郁药与他莫昔芬联合处方的趋势。
Breast Cancer Res Treat. 2013 Jan;137(1):285-96. doi: 10.1007/s10549-012-2330-z. Epub 2012 Nov 13.
9
Symptom management in metastatic breast cancer.转移性乳腺癌的症状管理。
Oncologist. 2011;16(9):1203-14. doi: 10.1634/theoncologist.2011-0159. Epub 2011 Aug 31.
10
Non-hormonal treatment strategies for vasomotor symptoms: a critical review.非激素治疗策略治疗血管舒缩症状:批判性评价。
Drugs. 2011 Feb 12;71(3):287-304. doi: 10.2165/11585360-000000000-00000.